Want to join the conversation?
$ILMN said that in 2Q16, the company exceeded its financial guidance. Revenue grew 11% year-over-year. In the Americas, revenue grew 13% and Asia-Pacific revenue grew 29%, driven primarily by China, which grew 70%. In Europe, revenue declined 4% compared to last year, slightly missing $ILMN's forecast.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?